Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature Review

Table 2

Summary of markers in 39 ESFT cases with pancreatic involvement reported to date.

Marker	Number of times reported positive
CD99	31 (78%)
Neuron specific enolase (NSE)	16 (40%)
Vimentin	12 (30%)
Synaptophysin	9 (23%)
Cytokeratin AE1/AE3	7 (18%)
Chromagranin	4 (10%)
S-100	4 (10%)
Epithelial membrane antigen	4 (10%)
PAS	3 (7.5%)
CD56	3 (7.5%)
Neural cell adhesion molecule	1 (2.5%)
FLI-1	1 (2.5%)
Cytokeratin 8	1 (2.5%)
CD45	1 (2.5%)
Alpha 1 antichromotrypsin	1 (2.5%)
CKM	1 (2.5%)
Progesterone receptor	1 (2.5%)
Estrogen receptor	1 (2.5%)
Inhibin	1 (2.5%)
Cyclin D	1 (2.5%)
Leu 7	1 (2.5%)
BCL-2	1 (2.5%)
CK 19	1 (2.5%)
CAM 5.2	1 (2.5%)
β-Catenin	1 (2.5%)
12E7	1 (2.5%)